BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 34210227)

  • 1. The role of a potential biomarker in patients with migraine: review and new insights.
    Ferreira KS; Dhillon H; Velly AM
    Expert Rev Neurother; 2021 Jul; 21(7):817-831. PubMed ID: 34210227
    [No Abstract]   [Full Text] [Related]  

  • 2. Biomarkers in Migraine.
    Yan BM; Gibson Depoy EM; Ahmad A; Nahas SJ
    Neurol India; 2021; 69(Supplement):S17-S24. PubMed ID: 34003145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers associated with migraine and their potential role in migraine management.
    Durham P; Papapetropoulos S
    Headache; 2013 Sep; 53(8):1262-77. PubMed ID: 23848170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin and Neuropeptides in Blood From Episodic and Chronic Migraine and Cluster Headache Patients in Case-Control and Case-Crossover Settings: A Systematic Review and Meta-Analysis.
    Frederiksen SD; Bekker-Nielsen Dunbar M; Snoer AH; Deen M; Edvinsson L
    Headache; 2020 Jun; 60(6):1132-1164. PubMed ID: 32293721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serological Biomarkers of Chronic Migraine.
    Cho S; Chu MK
    Curr Pain Headache Rep; 2023 Oct; 27(10):531-542. PubMed ID: 37561314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging drugs for the prevention of migraine.
    Ogunlaja O; Karsan N; Goadsby P
    Expert Opin Emerg Drugs; 2021 Sep; 26(3):271-280. PubMed ID: 34263680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum CGRP, VIP, and PACAP usefulness in migraine: a case-control study in chronic migraine patients in real clinical practice.
    Pérez-Pereda S; Toriello-Suárez M; Ocejo-Vinyals G; Guiral-Foz S; Castillo-Obeso J; Montes-Gómez S; Martínez-Nieto RM; Iglesias F; González-Quintanilla V; Oterino A
    Mol Biol Rep; 2020 Sep; 47(9):7125-7138. PubMed ID: 32951099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is calcitonin gene-related peptide a reliable biochemical marker of migraine?
    Tesfay B; Karlsson WK; Moreno RD; Hay DL; Hougaard A
    Curr Opin Neurol; 2022 Jun; 35(3):343-352. PubMed ID: 35674078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Migraine, Neurogenic Inflammation, Drug Development - Pharmacochemical Aspects.
    Lukacs M; Tajti J; Fulop F; Toldi J; Edvinsson L; Vecsei L
    Curr Med Chem; 2017; 24(33):3649-3665. PubMed ID: 28707585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of genetics on migraine induction triggered by CGRP and PACAP38.
    Guo S
    Dan Med J; 2017 Mar; 64(3):. PubMed ID: 28260603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Part II: Biochemical changes after pituitary adenylate cyclase-activating polypeptide-38 infusion in migraine patients.
    Guo S; Vollesen AL; Hansen YB; Frandsen E; Andersen MR; Amin FM; Fahrenkrug J; Olesen J; Ashina M
    Cephalalgia; 2017 Feb; 37(2):136-147. PubMed ID: 26994298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of serum CGRP measurement as a biomarker of chronic migraine: a critical reappraisal.
    Lee MJ; Lee SY; Cho S; Kang ES; Chung CS
    J Headache Pain; 2018 Jul; 19(1):53. PubMed ID: 30006780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging experimental drugs in clinical trials for migraine: observations and key talking points.
    Wells-Gatnik WD; Wences Chirino TY; Onan FN; Onan D; Martelletti P
    Expert Opin Investig Drugs; 2023; 32(8):761-771. PubMed ID: 37672405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcitonin gene-related peptide levels in tear fluid are elevated in migraine patients compared to healthy controls.
    Kamm K; Straube A; Ruscheweyh R
    Cephalalgia; 2019 Oct; 39(12):1535-1543. PubMed ID: 31603037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Major Targets Involved in Clinical Management of Migraine.
    Rushendran R; Chitra V; Ilango K
    Curr Neurovasc Res; 2023; 20(3):296-313. PubMed ID: 37488760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcitonin gene-related peptide in peripheral blood as a biomarker for migraine.
    Ramón C; Cernuda-Morollón E; Pascual J
    Curr Opin Neurol; 2017 Jun; 30(3):281-286. PubMed ID: 28234796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CGRP and migraine: could PACAP play a role too?
    Kaiser EA; Russo AF
    Neuropeptides; 2013 Dec; 47(6):451-61. PubMed ID: 24210136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging and future directions of migraine research and treatment.
    Chiang CC; Dodick DW
    Handb Clin Neurol; 2024; 199():583-597. PubMed ID: 38307672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of mast cells and their interactions with the trigeminal nerve in migraine headache.
    Guan LC; Dong X; Green DP
    Mol Pain; 2023; 19():17448069231181358. PubMed ID: 37232078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic changes in CGRP, PACAP, and PACAP receptors in the trigeminovascular system of a novel repetitive electrical stimulation rat model: Relevant to migraine.
    Zhang Q; Han X; Wu H; Zhang M; Hu G; Dong Z; Yu S
    Mol Pain; 2019; 15():1744806918820452. PubMed ID: 30799680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.